Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Enhancing the Risk Stratification of Severe Arboviral diseases using host-response Biomarkers in Brazil.

Project description

Improving early detection of severe arboviral disease

Arboviruses are becoming increasingly prevalent and pose a global health threat. Improved risk assessment tools are needed, as current methods lack accuracy. Evidence suggests that immune activation markers can help identify severe cases, but data specific to arboviruses remain limited. Supported by the Marie Skłodowska-Curie Actions programme, the RISE-ARBB project will improve early identification of severe arboviral diseases by evaluating host-response biomarkers in a prospective cohort study using the Luminex platform. Specifically, it will test two new point-of-care rapid triage tests that quantify the markers, as well as develop an algorithm that combines the best-performing markers with clinical severity indicators to enhance clinical guidelines. The study will involve about 2 000 individuals across three Brazilian hospitals.

Objective

Arboviruses such as dengue, Zika, and chikungunya, are experiencing a rapid surge in incidence and geographical distribution, representing a global public health threat. Improved risk assessment tools for arboviral diseases are urgently needed to enhance clinical management, since current risk stratification is based on algorithms with limited prognostic accuracy. Strong evidence suggests that immune and endothelial activation markers can reliably identify infections likely to progress to severe outcomes; however, data on specific arboviruses are scarce and conflicting.

The main aim of RISE-ARBB is to enhance early identification of severe arboviral diseases. The specific objectives are to: (1) evaluate head-to-head a wide panel of host-response biomarkers for early identification of severe arboviral diseases, using a large prospective cohort study and Luminex platform; (2) assess the prognostic performance of two novel point-of-care rapid triaging tests based on the quantification of sTREM1 and Angpt2 markers; (3) develop an evidence-based algorithm integrating the best performing marker(s) with clinical severity indicators to improve clinical guidelines; and (4) develop an exploitation strategy, including regulatory and go-to-market plan.

Such objectives will be addressed through a prospective cohort study involving ~2,000 individuals over 1 year-old presenting with symptomatic arbovirus infection at emergency departments of 3 hospitals in Brazil, the global epicenter of arbovirus epidemics. The results have the ground-breaking potential to avoid preventable deaths and decrease health system costs during future arbovirus outbreaks and epidemics globally. This fellowship will enable me to upgrade my training in translational research on arboviral diseases in endemic settings and prognostic strategies for their management, while establishing a global network and laying the foundation for a successful ERC application and independent academic career.

Fields of science (EuroSciVoc)

This project has not yet been classified with EuroSciVoc.
Be the first one to suggest relevant scientific fields and help us improve our classification service

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-TMA-MSCA-PF-GF - HORIZON TMA MSCA Postdoctoral Fellowships - Global Fellowships

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-MSCA-2024-PF-01

See all projects funded under this call

Coordinator

FUNDACION PRIVADA INSTITUTO DE SALUD GLOBAL BARCELONA
Net EU contribution
€ 333 204,36
Address
C ROSSELLO 132 PLANTA 05
08036 Barcelona
Spain
Region
Este Cataluña Barcelona
Activity type
Research Organisations
Links
Total cost
No data

Partners (3)